First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy.
about
Biomarkers in preclinical cancer imaging.Positron emission tomography of high-grade gliomas.Preclinical Evaluation of 18F-ML-10 to Determine Timing of Apoptotic Response to Chemotherapy in Solid TumorsThe preclinical study of predicting radiosensitivity in human nasopharyngeal carcinoma xenografts by 18F-ML-10 animal- PET/CT imaging.Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy via Noninvasive PET Molecular Imaging Strategies of Multifactorial BioparametersChallenges and Approaches to Quantitative Therapy Response Assessment in Glioblastoma Multiforme Using the Novel Apoptosis Positron Emission Tomography Tracer F-18 ML-10.SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinicMultimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.In Vivo Evaluation of Radiofluorinated Caspase-3/7 Inhibitors as Radiotracers for Apoptosis Imaging and Comparison with [18F]ML-10 in a Stroke Model in the Rat.[18F]ML-10 Imaging for Assessment of Apoptosis Response of Intracranial Tumor Early after Radiotherapy by PET/CT.Clinical translation of [F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer
P2860
Q30416864-E3BA98FE-2DC0-4170-8D35-5918253CCEC7Q31047940-FB86CC48-D35E-4BCE-98F4-D02B7C5FF8E6Q33793270-55CD5F33-9896-49B7-910D-C1CA45FD1BE9Q37190427-EA9F3669-F009-4AA8-A9DA-7CF6A501E8E4Q37291272-E4A2FFE3-5E94-4D2A-B87C-1D7CEB23D378Q37721557-D872C94E-2757-411B-997B-0F915CAA33D1Q37746356-6169E17E-04EB-4B60-B5FF-89BB9DABA391Q38822001-04EAF718-82F4-4637-9D89-251C6C98A688Q48158781-B5F321E6-B563-40BE-878F-6BB10314A063Q55500282-77E01DC4-4EA9-48DD-B8C9-49CC75CBA805Q59127014-64F64D37-EEB7-4FFA-8162-AED5B8CD8896
P2860
First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
First use of (18)F-labeled ML- ...... efore and early after therapy.
@en
First use of
@nl
type
label
First use of (18)F-labeled ML- ...... efore and early after therapy.
@en
First use of
@nl
prefLabel
First use of (18)F-labeled ML- ...... efore and early after therapy.
@en
First use of
@nl
P2093
P2860
P356
P1433
P1476
First use of (18)F-labeled ML- ...... efore and early after therapy.
@en
P2093
Charles M Laymon
Frank S Lieberman
James M Mountz
Jan Drappatz
Matthew J Oborski
Ronald L Hamilton
P2860
P304
P356
10.1002/BRB3.217
P577
2014-02-12T00:00:00Z